Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
LCY Group is a global chemical company that has expanded significantly into the biotechnology and life sciences sectors. The company is a major producer of high-purity solvents and pharmaceutical-grade chemicals, including isopropyl alcohol used in medical and laboratory applications. Through its subsidiary LCY Biosciences, the group operates a large-scale biorefinery that utilizes synthetic biology and fermentation to produce bio-succinic acid, a sustainable building block for various industries. LCY Group is recognized for its focus on green chemistry and the circular economy, aiming to replace petroleum-based processes with renewable alternatives. Following its acquisition by a KKR-led consortium in 2019, the company continues to invest in R&D for sustainable materials and global manufacturing expansion.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on LCY Group.